Diana Blithe, Ph.D., joined the Contraceptive Development Branch in 1996 from the NICHD's Division of Intramural Research. She has expertise in biochemistry, endocrinology, and glycobiology. Dr. Blithe is the Program Director for the Contraceptive Development Research Centers Program and the Male Contraceptive Development Program. She also serves as the Co-Director of the Contraceptive Clinical Trials Network, overseeing clinical trials to evaluate the safety and efficacy of new contraceptive agents for men and women. Dr. Blithe is the PI on a Collaborative Research and Development Agreement with HRA Parma to develop CDB-2914 as a Progesterone Receptor Modulator for contraceptive and therapeutic applications. Her additional responsibilities in the Branch include reviewing technology transfer arrangements with commercial partners. Dr. Blithe currently serves on the editorial board of Endocrine, and as an ad hoc reviewer for Endocrinology, The Journal of Clinical Endocrinology and Metabolism and other journals.